Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Drug Discovery Today
|
June 17, 2014
New advances in treating thrombotic diseases: GPVI as a platelet drug target
Peng Jiang, Martine Jandrot-Perrus
Blood
|
May 19, 2022
GPVI and collagen: the final word?
Alexandre Slater, Martine Jandrot-Perrus
European Heart Journal
|
April 2, 2025
Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs
Pierre H Mangin, Martine Jandrot-Perrus
Platelets
|
May 10, 2019
Platelet glycoprotein VI genetic quantitative and qualitative defects
Martine Jandrot-Perrus, Cedric Hermans, Diego Mezzano
European Journal of Biochemistry
|
July 9, 2003
Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin
Frédéric Adam, Marie-Claude Guillin, Martine Jandrot-Perrus
European Journal of Pharmacology
|
August 19, 2003
Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin
Mounsif Haloui, Olivier Meilhac, Martine Jandrot-Perrus, et al.
Trends in Molecular Medicine
|
November 8, 2003
Thrombin interaction with platelet membrane glycoprotein Ib alpha
Frédéric Adam, Marie-Christine Bouton, Marie-Geneviève Huisse, et al.
Journal De La Societe De Biologie
|
July 27, 2007
[Antithrombotic recombinant antibodies]
Julien Muzard, Stéphane Loyau, Nadine Ajzenberg, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 5, 2013
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
Fatma Berri, Vuong Ba Lê, Martine Jandrot-Perrus, et al.
Mabs
|
June 10, 2017
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks
Kristell Lebozec, Martine Jandrot-Perrus, Gilles Avenard, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Drug Discovery Today
|
June 17, 2014
New advances in treating thrombotic diseases: GPVI as a platelet drug target
Peng Jiang, Martine Jandrot-Perrus
Blood
|
May 19, 2022
GPVI and collagen: the final word?
Alexandre Slater, Martine Jandrot-Perrus
European Heart Journal
|
April 2, 2025
Glycoprotein VI inhibitors: glenzocimab and EMA601 two inhibitory Fabs
Pierre H Mangin, Martine Jandrot-Perrus
Platelets
|
May 10, 2019
Platelet glycoprotein VI genetic quantitative and qualitative defects
Martine Jandrot-Perrus, Cedric Hermans, Diego Mezzano
European Journal of Biochemistry
|
July 9, 2003
Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin
Frédéric Adam, Marie-Claude Guillin, Martine Jandrot-Perrus
European Journal of Pharmacology
|
August 19, 2003
Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin
Mounsif Haloui, Olivier Meilhac, Martine Jandrot-Perrus, et al.
Trends in Molecular Medicine
|
November 8, 2003
Thrombin interaction with platelet membrane glycoprotein Ib alpha
Frédéric Adam, Marie-Christine Bouton, Marie-Geneviève Huisse, et al.
Journal De La Societe De Biologie
|
July 27, 2007
[Antithrombotic recombinant antibodies]
Julien Muzard, Stéphane Loyau, Nadine Ajzenberg, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 5, 2013
Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits
Fatma Berri, Vuong Ba Lê, Martine Jandrot-Perrus, et al.
Mabs
|
June 10, 2017
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks
Kristell Lebozec, Martine Jandrot-Perrus, Gilles Avenard, et al.
Page
of 12